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Abstract
Serratiamarcescens is an important nosocomial pathogen that can cause an array of infections, most notably of the urinary tract and
bloodstream. Naturally, it is found in many environmental niches, and is capable of infecting plants and animals. The emergence and
spread of multidrug-resistant strains producing extended-spectrum or metallo beta-lactamases now pose a threat to public health
worldwide. Here we report the complete genome sequences of two carefully selected S. marcescens strains, a multidrug-resistant
clinical isolate (strainSM39)andan insect isolate (strainDb11).Ourcomparativeanalyses reveal thecoregenomeofS.marcescensand
define the potential metabolic capacity, virulence, and multidrug resistance of this species. We show a remarkable intraspecies
geneticdiversity, bothat the sequence level andwith regardsgenomeflexibility,which may reflect the diversityof niches inhabited by
members of this species. A broader analysis with other Serratia species identifies a set of approximately 3,000 genes that characterize
the genus. Within this apparent genetic diversity, we identified many genes implicated in the high virulence potential and antibiotic
resistance of SM39, including the metallo beta-lactamase and multiple other drug resistance determinants carried on plasmid
pSMC1. We further show that pSMC1 is most closely related to plasmids circulating in Pseudomonas species. Our data will provide
a valuable basis for future studies on S. marcescens and new insights into the genetic mechanisms that underlie the emergence of
pathogens highly resistant to multiple antimicrobial agents.
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Introduction
Serratia species are ubiquitous in the environment, and are
found in water and soil as well as associated with plants, in-
sects, humans, and other animals. The genus Serratia belongs
to the family Enterobacteriaceae and comprises at least 14
species with two subspecies (Mahlen 2011). Among these
Serratia species, S. marcescens is the one most commonly as-
sociated with human infections. Originally considered as non-
pathogenic, it is now recognized as an important nosocomial
pathogen capable of causing urinary tract infections (Maki
et al. 1973; Okuda et al. 1984; Su et al. 2003), bloodstream
infections including endocarditis (Korner et al. 1994), and
many other types of infections (Yu 1979). Several potential
virulence factors of S. marcescens have been identified, includ-
ing hemolysin (Goluszko and Nowacki 1989; Shimuta et al.
2009), proteases (Lyerly et al. 1981; Lyerly and Kreger 1983),
lipopolysaccharide (LPS) (Makimura et al. 2007), fimbriae
(Parment et al. 1992), and siderophores (Letoffe et al.
1994). The pathogenicity and genomic plasticity of members
of this species are, however, yet to be fully understood.
One other important feature of S. marcescens as a nosoco-
mial pathogen is its intrinsic and acquired resistance to antimi-
crobial agents. Many of the clinical isolates of this organism
carry chromosomal and plasmid-encoded genetic determi-
nants specifying resistance to a wide range of antibiotics
(Mahlen 2011) including extended-spectrum beta-lactamase
(ESBL) or metallo beta-lactamase (MBL). For example, surveys
in Poland (1996–2000) in two hospitals showed 19% (67/354)
of S.marcescens isolates produced ESBL (Naumiuk et al. 2004).
Similarly in Taiwan (2001–2002), 12% (15/123) were ESBL
producers and the 30-day mortality rate of patients with
ESBL-producing S. marcescens was 33% (Cheng et al.
2006). MBL-producing S. marcescens are clinically more prob-
lematic because they show a high level resistance to a wider
range of beta-lactams including carbapenem. A representative
MBL enzyme, IMP-1, was first seen in a S. marcescens clinical
isolate in 1991 in Japan (Osano et al. 1994). Since then various
types of MBL have been identified in many S. marcescens
strains (Wachino et al. 2011), including those causing out-
breaks (Herbert et al. 2007; Nastro et al. 2013).
Here, we report and compare the complete genome se-
quences of two S. marcescens strains; a clinical isolate that
showed a high level multidrug resistance (strain SM39) and a
spontaneous streptomycin-resistant mutant derived from the
strain Db10 originally isolated from a moribund fly (strain
Db11). Our analysis reveals a possible core genome of S. mar-
cescens and accessory genomes specific to each strain, pro-
viding insights into the high virulence potential of the clinical
isolate. We found that the extremely high level of multidrug
resistance of strain SM39 was due to the presence of the
plasmid pSMC1, which encodes MBL and several other drug
resistance determinants. We propose a scenario for the origin
and evolution of pSMC1, based on its genomic features.
Materials and Methods
S. marcescens Strains, Culture Media, and
Growth Conditions
Strain SM39 was isolated from a septicemic patient in Japan in
1999 (Nakamura et al. 2002). Strain Db11, a kind gift from
Dominique Ferrandon, is a spontaneous streptomycin-resis-
tant derivative of strain Db10 which was isolated from a mor-
ibund Drosophila melanogaster in Sweden (Flyg et al. 1980). It
is available, together with Db10, from the Caenorhabditis
Genetics Center (http://www.cbs.umn.edu/CGC, last accessed
August 6, 2014). For routine bacterial cultivation, the strains
were aerobically grown at 37 C in Luria–Bertani (LB) broth
with shaking or on LB agar plates.
Genome Sequencing, Gene Prediction, and Annotation
Genomic DNA was prepared from overnight cultures of the
two strains using the Genomic-tip 100/G and Genomic DNA
buffer set (Qiagen, Inc.) according to the manufacturer’s in-
structions. The genome of SM39 was shotgun sequenced to
approximately 12-fold coverage from 102,218 end sequences
of two genomic shotgun libraries based on pUC118 and
pCC1BAC with average insert sizes of 3 and 10 kb, respec-
tively. The genome of Db11 was shotgun sequenced to ap-
proximately 10-fold coverage from 90,142 end sequences
from multiple shotgun libraries: pMAQ1Sac_BstXI (with
insert sizes of 5.5–6, 9–10, and 10–12 kb), pUC19 (with
insert sizes of 1.4–2 and 2–2.8 kb), pOTWI2 (with insert
sizes of 3–3.3 and 2–2.8 kb), and M13mp18 (with insert
sizes of 1–1.4, 0.4–0.8, 1–1.4, and 0.5–1 kb). This was sup-
plemented by approximately 0.2-fold coverage from 1,713
end sequences derived from large insert fosmid libraries:
pBACe3.6_BamHI with an insert size 18–23 kb. All sequencing
was performed using big-dye terminator chemistry on
ABI3730 or ABI3700 capillary automated sequencers
(Applied Biosystems). All assemblies were generated using
Phrap. All repeat regions, gaps and low quality regions were
bridged using large insert fosmid libraries, read-pairs, or end-
sequenced polymerase chain reaction (PCR) products. The se-
quences were manipulated to the community standard of
“Finished” (Chain et al. 2009).
Nucleotide sequence position 1 of each chromosome was
assigned according to that of published Escherichia coli ge-
nomes. Gene prediction and annotation were performed
using Microbial Genome Annotation Pipeline (Sugawara
et al. 2009), followed by manual curation on the basis of
the results of BLASTP homology search against the public
nonredundant protein database (http://www.ncbi.nlm.nih.
gov/, last accessed August 6, 2014). The annotated genome
sequences of SM39 and Db11 have been deposited to the
DDBJ/EMBL/GenBank database under the accession numbers
AP013063 for the SM39 chromosome, AP013064 for the
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pSMC1 plasmid of SM39, AP013065 for pSMC2 of SM39,
and HG326223 for the Db11 chromosome.
Genome-Wide Comparative Analysis
Intra- and interstrain clustering analyses of protein coding se-
quences (CDSs) were performed based on the results of all-to-
all BLASTP analysis with a threshold of 90% amino acid se-
quence identity over 90% aligned length of the query se-
quence (supplementary fig. S1, Supplementary Material
online, for details). In Silico Molecular Cloning (InSilico
Biology, Yokohama, Japan) was used for genome sequence
comparison. The average nucleotide identity (ANI) was calcu-
lated using the JSpecies software (Richter and Rossello-Mora
2009). Multiple alignments of sequences were constructed
using the ClustalW program (Thompson et al. 1994) and a
neighbor-joining tree was generated using the Tamura–Nei
model in MEGA5 (Tamura et al. 2007). Pathway analysis was
performed using the KEGG (Kyoto Encyclopedia of Genes and
Genomes) online database (Kanehisa and Goto 2000). Signal
peptide-containing proteins were identified using the SignalP
4.1 server (http://www.cbs.dtu.dk/services/SignalP/, last
accessed August 6, 2014) (Petersen et al. 2011). For the in-
terspecies comparison, following four genomes were used: S.
proteamaculans strain 568 (GenBank accession number
CP000826) and S. plymuthica strains AS9 (CP002773)
(Neupane et al. 2012) and 4Rx13 (CP006250) (Weise et al.
2014), which were all isolated from plants, and S. odorifera
strain DSM4582 (from human sputum) (ADBY00000000).
Semiautomated Screen for Mutants with an Attenuated
Virulence Using Caenorhabditis elegans
A library of individual S. marcescensDb10 mini-Tn5Sm mutant
clones was generated using standard methods. Using a
COPAS Biosort (Union Biometrica, Boston), 30 L4 stage wild
type (N2) worms were sorted into the wells of 96-well plates
as previously described (Garvis et al. 2009). Then, 30ml of an
overnight culture (30 C in 200ml LB with 100mg/ml strepto-
mycin in 96-well plates) of individual mutant clones was trans-
ferred to the worm-containing wells. Assay plates containing
worms and bacteria were incubated at 25 C with agitation,
whereas overnight culture plates were kept at 4 C. A dupli-
cate assay was performed the following day, again with 30 L4
worms per well, using the same bacterial cultures. For this,
bacterial cultures were warmed up from 4 C to room tem-
perature for at least an hour before use. For each assay and its
duplicate, the number of worms alive in each well was scored
each day for 5 days by examination with a dissecting micro-
scope. Wells were scored as (<5 worms alive), + (5–9 alive),
++ (10–14 alive), and +++ (at least 15 alive). Mutants were
considered attenuated when they scored either ++ after 3
days, or + after 4 or 5 days, and were subsequently assayed
for worm killing on solid medium as previously described (Kurz
et al. 2003). The mini-Tn5-Sm insertion site in attenuated
mutants was determined by direct genomic DNA sequencing
(MilleGen, Labe`ge, France) with primers JEP131 and JEP132
(50-CGGCCGCACTTGTGTATAA-30 and 50-CTAGGCGGCCAG
ATCTGATCAA-30, respectively).
Construction of KS3, a pSMC1-Cured Derivative of SM39
Because the pSMC1 plasmid of SM39 is highly stable, we
could not obtain SM39-derivatives that have spontaneously
lost pSMC1. To obtain a pSMC1-cured derivative of SM39,
we first deleted the parABC genes (pSMC1_53-55) of pSMC1
using a method described by Masuda et al. (2000). The up-
stream and downstream parABC-flanking regions were am-
plified by PCR using primer pairs parAUF4/parAUR2 (50-GGAA
TTCAGCTAGCTTCTAGATGACCAGAAA-30 and 50-CAGAGAA
CAACAAGATAGATTTTAGCCGCTAAA-30) and parADF2/
parADR3 (50-GCTAAAATCTATCTTGTTGTTCTCTGTTATTCCC-
30 and 50-CTCGAGCTCTGTGCGCATCGAGTT-30), respectively.
The PCR products were concatenated by fusion PCR with
primers parAUF4 and parADR3. The concatenated DNA frag-
ment was inserted into pLOI2223 to yield pPAR001, and then
a NotI fragment of pMT5071, which encodes the Mob cas-
sette, was inserted into pPAR001 to yield pPAR002. pPAR002
was mobilized conjugally from E. coli strain S17-1 to S. mar-
cescens SM39. Transconjugants, in which pPAR002 was in-
serted into pSMC1 (the first recombination), were selected on
BM2 plates containing 150mg/ml of chloramphenicol (Cm)
and sucrose-sensitive clones were further screened using su-
crose (10%)-containing and sucrose-free LB plates. Insertion
of pPAR002 into pSMC1 was confirmed by PCR, and then
pPAR002 excision (with or without the parABC genes) was
selected on sucrose LB plates. Cm-susceptible clones were
screened by PCR for the loss of the parABC genes. SM39-
derivatives cured of pSMC1 were sensitive to HgCl2 (16mg/
ml in LB plates). The loss of pSMC1 was finally confirmed by
plasmid profiling, and one of these derivatives (designated as
KS3) was used for further analysis. See supplementary figure
S2, Supplementary Material online, for the entire process and
the composition of BM2 medium.
Antimicrobial Susceptibility Testing
Minimum inhibitory concentrations (MICs) of strains SM39,
KS3, and Db11 against 36 antimicrobial agents were deter-
mined by the usual 2-fold agar dilution technique with
Mueller-Hinton II agar (Becton Dickinson Microbiology
Systems, Cockeysville, MD) with an inoculum size of 104
cells as described previously (Masuda et al. 2000).
Results and Discussion
Comparative Genomics of Human Clinical and Insect
Pathogenic S. marcescens Strains SM39 and Db11
The chromosomes of SM39 and Db11 are similar in size,
5,225,577 and 5,113,802 bp, respectively, and gene
Iguchi et al. GBE
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number (table 1 and fig. 1A). SM39 carries two plasmids,
pSMC1 (41,517 bp) and pSMC2 (58,929 bp). No extrachro-
mosomal elements were found in Db11. Overall, the chromo-
somes of the two strains are highly conserved and essentially
collinear, except for a large inversion of the oriC region flanked
by rRNA operons (fig. 1B). Surprisingly for members of the
same species, the ANI between the conserved genomic re-
gions of the two strains (4,391 kb) is only 95.1%. This can
be compared with a figure of 97.0% for the ANI between two
distantly related members of E. coli, strains K-12 and E2348/
69. Despite this, the 16S rRNA genes of the two strains show
99.4% sequence identity, consistent with DB11 and SM39
being members of the same species (Kim et al. 2014; see
also supplementary fig. S3, Supplementary Material online).
Further with a criterion of90% nucleotide sequence identity
and 5 kb length, we identified 44 genomic regions specific
to SM39, totaling 628 kb (12% of the genome), and 39 spe-
cific regions (447 kb or 8.7% of the genome) for Db11
(fig. 1A; see also supplementary tables S1 and S2,
Supplementary Material online). The relatively low ANI value
for the two S. marcescens strains and the considerable
amount of isolate-specific sequences may reflect the diversity
of niches that this species can occupy.
To extend the analysis of unique and shared genes be-
tween the two strains, we performed a clustering analysis of
the SM39 and Db11 CDSs using an all-against-all BLASTP ap-
proach (outlined in supplementary fig. S1, Supplementary
Material online). This showed that 3,970 genes (or gene fam-
ilies) were conserved in both strains with additional 860
SM39-specific and 728 Db11-specific genes (fig. 2A).
Functional classification of these genes based on the Cluster
of Orthologous Groups (COG) categories indicated that genes
belonging to “category L (replication, recombination, and re-
pair)” and “category V (defense mechanisms)” are more
FIG. 1.—The chromosomes of Serratia marcescens strains SM39 and
Db11. (A) Circular maps of the SM39 and Db11 chromosomes. From the
outside in, the first circle shows the nucleotide sequence positions (in Mb),
and the second circle shows the locations of strain-specific regions of
5 kb (purple: prophages and integrative elements; red: others) with an
indication of their features and/or encoded products/functions (PP, pro-
phages; IE, integrative elements; EPS, exopolysaccharide biosynthesis). The
third and fourth circles show CDSs transcribed clockwise and anticlock-
wise, respectively (yellow: CDSs conserved in both strains, blue: CDSs
specific to one strain), the fifth circle the rRNA operons, the sixth circle
the G+C content, and the seventh circle the GC skew. (B) Dot plot pre-
sentation of DNA sequence homologies between the chromosomes.
Locations of ori and seven rRNA operons (rrn1–rrn7) are indicated.
Table 1
Genomic Features of Serratia marcescens Strains SM39 and Db11
Strains SM39 Db11
Chromosome
Size (bp) 5,225,577 5,113,802
GC content (%) 59.8 59.5
CDSsa 4,866 (19) 4,722 (15)
rRNA operons 7 7
tRNAs 87 87
Prophages 7 2
Integrative elements 2 4
IS elements 17 5
Plasmid s pSMC1 pSMC2 None
Size (bp) 41,517 58,929 —
GC content (%) 61.5 51.9 —
CDSsa 55 (4) 72 (0) —
IS elements 1 0 —
aThe number of pseudogenes is indicated in parentheses.
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highly represented in SM39 than in Db11 (fig. 2B). These dif-
ferences are largely attributable to the presence of more
genes associated with lateral gene transfer in SM39 such as
insertion sequence (IS) transposases and integrases (category
L), and genes for restriction-modification systems and multi-
drug transport systems (category V). For example, SM39 car-
ries a higher variety and number of IS elements: 18 compared
with the 5 carried by Db11 (table 1). These IS elements were
classified into 11 distinct types, nine of which represent novel
IS elements. Eight types were found in SM39 and four in
Db11, with only ISSe5 being shared by both isolates (supple-
mentary table S3, Supplementary Material online). More pro-
phages were also found in SM39 (seven) than in Db11 (only
two), with none of the prophages and other integrative ele-
ments being shared by the two strains (table 1 and supple-
mentary table S4, Supplementary Material online).
We further compared the S. marcescens gene sets with
those of four sequenced strains from other Serratia species:
S. proteamaculans strain 568 and S. plymuthica strains AS9
(Neupane et al. 2012) and 4Rx13 (Weise et al. 2014), which
were all isolated from plants, and S. odorifera strain DSM4582
(from human sputum). This showed that only 23% and 38%
of the genes that we denoted as SM39- or Db11-specific had
homologs in these isolates representing other Serratia species
(fig. 2C). In contrast, 71% (2,852 genes) of the 3,970 core
genes shared by the two S. marcescens strains were conserved
in all the four isolates representing other Serratia species. This
suggests that, despite the genetic diversity of this genus (see
supplementary fig. S3, Supplementary Material online, for the
phylogenetic relationship of these species in genus Serratia),
there is a relatively large shared or core genome of 2,852
CDSs. This analysis also identified 358 genes that are con-
served in the two S. marcescens strains but absent in other
Serratia species. This group includes a number of genes related
to pathogenicity in other bacteria (data not shown).
Common and Strain-Specific Metabolic Capabilities in
S. marcescens SM39 and Db11
Central metabolic pathways are well conserved between the
two strains and characteristic of the species as a whole:
Positive fermentation for sucrose and D-sorbitol, and negative
for D- and L-arabinose, L-rhamnose, D-xylose and cellubiose.
Not uncommonly, both isolates lack the genes for prodigiosin
biosynthesis, the characteristic red pigment often associated
with S. marcescens (Harris et al. 2004). The differences be-
tween the two isolates include, for carbohydrate metabolism,
alternative pathways for L-ascorbate utilization; the ula-type
encoded pathway is carried by SM39 (SM39_4088-4095) and
the sgb-type by Db11 (SMDB11_3334-3337). Major differ-
ences in nitrogen metabolism are also observed between
FIG. 2.—Comparison of the gene contents of SM39 and Db11. (A) Venn diagram showing the numbers of conserved and strain-specific CDSs. (B) COG
category-based functional analysis of each group of CDSs, the conserved and strain-specific CDSs. J: translation, ribosomal structure, and biogenesis; K:
transcription; L: replication, recombination, and repair; D: cell cycle control, cell division chromosome partitioning; V: defense mechanisms; O: posttrans-
lational modification, protein turnover, and chaperones; T: signal transduction mechanisms; M: cell wall/membrane/envelope biogenesis; U: intracellular
trafficking, secretion, and vesicular transport; N: Cell motility; C: energy production and conversion; G: carbohydrate transport and metabolism; E: amino acid
transport and metabolism; F: nucleotide transport and metabolism; H: coenzyme transport and metabolism; I: lipid transport and metabolism; P: inorganic
ion transport and metabolism; Q: secondary metabolites biosynthesis, transport, and catabolism; R: general function prediction only; S: function unknown.
(C) Conservation of each group of CDSs in four strains of other Serratia species (S. proteamaculans 568, S. odorifera DSM4582, S. plymuthica 4Rx13, and
S. plymuthica AS9).
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the two isolates: Unlike Db11, SM39 carries the nrtABC
operon (SM39_1878-1880) encoding an ATP-binding cassette
(ABC) transporter for nitrate/nitrite, the nasAC operon
(SM39_1885 and SM39_1886) encoding a nitrate reductase,
and the nasB gene (SM39_1884) encoding a nitrite reductase
(all in the SM39_E18 region; supplementary table S1,
Supplementary Material online). Thus SM39 appears to have
a potential capacity to utilize nitrate, which is present in urine,
as a nitrogen source. Related to this, both SM39 and Db11
carry an operon necessary for the metabolism of allantoin but
lack the allB gene encoding allantoinase (Cusa et al. 1999).
Allantoin is the principal nitrogen source in urine in most
mammals. Humans and nonhuman primates, however,
carry a genetic lesion, thus rather than allantoin, they accu-
mulate urate that can be catabolized despite the loss of allB.
Together, these genes could be associated with the potential
capacity of S. marcescens strains to grow in urine and cause
urinary tract infections in humans (Mahlen 2011).
Diversity and Differential Evolution of the Potential
Virulence of S. marcescens SM39 and Db11
Serratia marcescens is well known for its ability to secrete nu-
merous exoenzymes and other proteins. We identified many
known or predicted secreted or surface-exposed proteins po-
tentially related to virulence, most of which (30/40) are con-
served in both strains (supplementary table S5, Supplementary
Material online).
Surface Structures and Polysaccharides
Here again, the genomic analysis revealed conservation and
specialization of the outer surface of the two sequenced
strains. Serratia marcescens is characteristically motile, and
both strains carry a complete E. coli-like gene set for the bio-
synthesis of flagella and for chemotaxis (supplementary table
S6, Supplementary Material online). These gene sets are highly
conserved between SM39 and Db11, the exception being the
ﬂiC flagellin-encoding gene, which shows a remarkable se-
quence diversity (only 68.3% identity in the amino acid se-
quence). Variation in flagellin structure is linked with antigenic
variation and differences in the helicity of the flagellum that in
turn are associated with niche adaptation.
Both Db11 and SM39 possess multiple operons for the
biosynthesis of chaperone–usher fimbriae associated with
biofilm formation and attachment to biotic and abiotic sur-
faces (Labbate et al. 2007; Shanks et al. 2007). Among these,
six are conserved in the two strains (two are significantly di-
vergent in sequence), but three and four are specific to SM39
and Db11, respectively (fig. 3). In addition, although both
strains contain a complete set of type IV fimbriae-related
genes (Sauvonnet et al. 2000; Kulkarni et al. 2009;
Xicohtencatl-Cortes et al. 2009) (supplementary table S7,
Supplementary Material online), only SM39 contains a ho-
molog (SM39_0944) of yagZ/ecpA/matB, the gene for E. coli
common pili (also known as Mat fimbriae) (Pouttu et al.
2001; Rendon et al. 2007).
Although the SM39 and Db11 LPS core polysaccharide bio-
synthesis gene clusters (the waa genes) are broadly similar,
FIG. 3.—Fimbriae operons identified in SM39 and Db11. The gene
organization of the operons for biosynthesis of chaperone-usher fimbriae
identified in SM39 and Db11 is shown. (A) Operons “conserved” between
the two strains showing a high sequence identity (>95% amino acid se-
quence identity for all gene products) and (B) genes in the “diversified”
operons show low sequence identity (up to 86% amino acid sequence iden-
tity). Note that both strains contain a set of type IV fimbriae-related genes,
orthologs of which have been identified of Escherichia coli, and that a ho-
mologue (SM39_0944) of yagZ/ecpA/matB, the gene for E. coli common pili
(also known as Mat fimbriae) was found in SM39 but not in Db11.
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there is significant sequence divergence (25–71% amino acid
sequence identity for the corresponding predicted proteins)
in four orthologous genes (SM39_4551-4554 and
SMDB11_4052-4055) in this cluster. These four genes
encode two glycosyltransferases, a polymer ligase (WaaL),
and an UDP-galactose-4-epimerase. Those of Db11 showed
high similarity to those of S. marcescens strain N28b serovar
O4 (Coderch et al. 2004). These data suggest that at least two
LPS core types exist in S. marcescens.
The gene cluster for O antigen biosynthesis was identified
between the S-layer biosynthesis gene cluster and the his
operon in both strains (fig. 4). As expected, the gene contents
of the loci significantly differ between the two strains; Db11
was serotyped conventionally as O28:K7, whereas SM39 was
untypeable. There is also good evidence from the genome se-
quences that both strains carry a complete gene cluster for
group 1 capsule polysaccharide (CPS) biosynthesis, equivalent
to the colanic acid biosynthesis genes in E. coli. Differences in
gene content in this region suggest, however, that the two
strains produce different types of group 1 CPS (fig. 4). This
will need to be addressed experimentally in future studies.
Secretion Systems and Secreted Proteins
One unexpected difference between Db11 and SM39 is the
presence of a type II secretion system (T2SS) in SM39 but not
in Db11 (supplementary fig. S4, Supplementary Material
online). The T2SS is a multiprotein secretion complex, present
in a wide variety of organisms and frequently implicated in
virulence (Korotkov et al. 2012). Although the substrates of
the SM39 T2SS are unknown, it could well contribute to the
virulence of SM39.
Multiple type V secretion systems (T5SSs) are present in
SM39 and Db11. T5SSs include both autotransporters and
two-partner systems (Grijpstra et al. 2013; Jacob-Dubuisson
et al. 2013). An archetypal example of a two-partner T5SS is
ShlBA; the hemolysin ShlA is one of the known major viru-
lence factors in S. marcescens (Goluszko and Nowacki 1989).
The shlBA operon is conserved in both strains. In contrast,
three additional gene clusters, encoding two-partner systems
with partial similarity to ShlA and other haemagglutinin-like
proteins, were identified only in SM39 (fig. 5). Two of these,
SM39_2080-2077 and SM39_3145-3141, appear to encode
contact-dependent inhibition (Cdi) systems. In such systems,
CdiB is a translocator protein that assembles the large, hemag-
glutinin domain-containing CdiA passenger protein on the cell
surface (Aoki et al. 2010). Variable toxin domains are found at
the C-terminus of CdiA (CdiACt), which mediate contact-de-
pendent growth inhibition of competitor bacteria.
Additionally, immunity proteins (CdiI) cognate to the CdiACt
are encoded downstream of CdiA. Both loci contain a typical
cdiBAI arrangement. The SM39_3144 locus also includes an
“orphan” CdiACt–CdiI paizr (SM39_3142-3141). Orphan
CdiACt–CdiI pairs contain truncated CdiA C-termini thought
to represent remnants or reservoirs of alternative toxin do-
mains, which can be exchanged to provide new antibacterial
capability (Poole et al. 2011).
Both SM39 and Db11 contain Lip (lipase) and Has (hemo-
phore) type I secretion systems (Kanonenberg et al. 2013), and
both possess a single type VI secretion system (T6SS) con-
served between the two strains (supplementary fig. S5,
Supplementary Material online). T6SS can be used by bacteria
either to target eukaryotic cells as a direct virulence
FIG. 4.—Comparison of the SM39 and Db11 genomic loci bearing exopolysaccharide biosynthesis gene clusters. The gene organization of the gene
clusters for O antigen biosynthesis and for group 1 CPS biosynthesis is compared between SM39 (untypeable) and Db11 (O28:K7). The O antigen
biosynthesis genes of SM39 and Db11 show high level of similarities to those of Klebsiella pneumoniae O8 and those of K. pneumoniae O5, respectively.
The Db11 operon also has a high level of similarity to that of Escherichia coli O8 (Iguchi A, Iyoda S, Kikuchi T, Ogura Y, Katsura K, Ohnishi M, Hayashi T and
Thomson NR, unpublished data), consistent with the cross-reactivity between SerratiamarcescensO28, K. pneumoniaeO5, and E. coliO8 antigens previously
reported by Aucken and Pitt (1991).
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mechanism or to kill rival bacterial cells as a competitive fitness
mechanism (Coulthurst 2013). The S. marcescens T6SS has
been shown to have potent bacterial killing activity
(Murdoch et al. 2011). Furthermore, six effectors (antibacterial
toxins) secreted by this system have recently been identified in
Db11, together with cognate immunity proteins that protect
against self-toxicity (English et al. 2012; Fritsch et al. 2013). Of
these, the Ssp1 and Ssp2 effectors, Tae4-family peptidoglycan
amidases which attack the target cell wall, and associated Rap
(Tai4) immunity proteins are encoded within the T6SS gene
cluster (supplementary fig. S5, Supplementary Material
online). Overall, the T6SS gene clusters of Db11 and SM39
are very similar with some significant differences: Although
the Ssp1–Rap1a effector–immunity pair is conserved, the “or-
phan” Rap1b immunity protein is missing from SM39 and
Ssp2 has been replaced by a new effector–immunity pair,
belonging to the same Tae4–Tai4 family but clearly distinct.
This strongly suggests that the T6SS antibacterial activity of S.
marcescens is highly specific and strain-dependent, as has
been observed experimentally (Murdoch et al. 2011).
Iron Uptake
Iron uptake is essential for bacterial growth within host organ-
isms because iron is sequestered by the host (Andrews et al.
2003). SM39 and Db11 possess multiple common sets of iron
acquisition systems with only a few differences. Although
some of the common systems are also found in other se-
quenced Serratia species (supplementary table S8,
Supplementary Material online), others, including a second
gene cluster for siderophore synthesis, fecIRA and fepBGDC
for transport of ferric compounds, and the has operon, are
restricted to S. marcescens. These species-specific iron uptake
systems might be associated with the higher virulence of
S. marcescens compared with other species of the genus.
Quorum-Sensing System
Quorum-sensing systems sense bacterial cell density and play
important roles in regulating the behavior of bacterial popu-
lation by controlling various biological processes, including
pathogenicity. None of the three N-acyl homoserine lactone
(AHL) quorum-sensing systems so far described in strains of S.
marcescens (SwrI/SwrR [Eberl, Christiansen et al. 1996; Eberl,
Winson et al. 1996], SpnI/SpnR [Horng et al. 2002], and SmaI/
SmaR [Coulthurst et al. 2006]) was found in SM39 or Db11.
Instead, we identified a candidate SM39-specific AHL system
comprising LuxI/LuxR family proteins (SM39_4838 and
SM39_4837), which show a high similarity (about 80%
amino acid sequence identity) to ExpR/ExpI of Erwinia tasma-
niensis (Muller et al. 2011). In contrast, no AHL quorum-
sensing system was found in Db11. These data indicate a
remarkable variation in the AHL quorum-sensing system
among S. marcescens strains.
FIG. 5.—Gene clusters for hemolysin/hemagglutin-like two-partner
Type V secretion systems identified in SM39 and Db11. (A) The gene
organization of the gene clusters for hemolysin/hemagglutin-like two-part-
ner systems in SM39 and Db11 is shown. TpsA components are the pas-
senger proteins (including the ShlA hemolysin and CdiA proteins) and TpsB
components are the cognate translocator proteins (including ShlB and
CdiB proteins). Although the shlBA operon (image 1) is conserved in the
two strains, three additional gene clusters were found only in SM39. Two
of these, SM39_2080-2077 (image 3) and SM39_3145-3141 (image 4),
based on homology, encode Cdi systems. In addition to CdiA and CdiB
proteins, a third component conferring resistance to the C-terminal toxin
domain of CdiA is encoded downstream of CdiA, the CdiI immunity pro-
tein (SM39_2078 and SM39_3143, respectively). A putative “orphan”
CdiA C-terminus (including a distinct potential toxin domain) and cognate
CdiI pair is encoded by SM39_3142-3141. The function of the third SM39-
specific cluster, SM39_0386-0387 (image 2), is unknown. (B) Similarities
between the TpsA hemolysin/hemagglutin-related proteins (amino acid
sequence identity) are shown, with those newly identified in SM39 show-
ing partial similarity to ShlA.
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Variation of Nonribosomal Peptide Synthetase-Dependent
Secondary Metabolites and Weapons for
Interbacterial Competition
Diffusible inhibitory molecules include antibiotics and bacteri-
ocins (protein or peptide toxins targeting related organisms).
SM39 and Db11 have one and two bacteriocins, respectively,
not shared by the other, as well as two in common (including
bacteriocin 28b).
An operon of six genes specific to Db11 (SMDB11_2293-
2288, named alb1–alb6) encodes a hybrid nonribosomal pep-
tide synthetase (NRPS)-polyketide synthase (PKS) enzyme, plus
tailoring enzymes and a resistance-conferring efflux pump.
This cluster was recently identified as required for the ability
of Db10 to produce a diffusible antimicrobial compound and
shown to direct the synthesis of a broad-spectrum antibiotic
called althiomycin (Gerc et al. 2012). Two predicted NRPS
enzymes are found only in SM39 and may also be involved
in biosynthesis of antimicrobial molecules. These variations,
along with those in T6SS and Cdi systems, suggest that in-
terbacterial competition in microbial communities is one of the
important drivers of genomic diversity in S. marcescens.
NRPS-dependent molecules also have other roles. In Db11,
SMDB11_3680, or SwrA, produces the biosurfactant
Serrawettin W2 (Pradel et al. 2007). In SM39, SM39_3884
shares only 56% identity with SwrA but, given that it is
encoded in the same genomic locus and has a very similar
domain organization, it probably synthesizes a related biosur-
factant molecule. Three other NRPSs are shared by both
strains, including two involved in synthesis of the two side-
rophores mentioned earlier.
In Vivo Screening Shows That Many Core S. marcescens
or Serratia sp. Genes Are Involved in Virulence in an
Invertebrate Model Host
Db10 was isolated fromD.melanogaster (Flyg et al. 1980), but
it is pathogenic in several other infection models, including C.
elegans and mice. Previous work has shown that there is a
substantial overlap between the genes required for full viru-
lence of S. marcescens during infection of flies and C. elegans
(Kurz et al. 2003). Thus, as the nematode is well-suited to
automated screens (Kurz and Ewbank 2007; Garvis et al.
2009), we used it to look for new S. marcescens virulence
factors and to determine whether genes associated with vir-
ulence were within the shared or accessory gene sets. We
constructed a mini-Tn5-Sm transposon mutant library in
Db10 and assayed clones in a high-throughput screen to iden-
tify mutants with a reduced ability to kill C. elegans. From the
12,480 individual Db10-derived clones that were tested, 12
mutants (0.1% of all the mutants screened) were selected as
showing the most robust reduction in virulence.
The mini-Tn5-Sm insertion site in each mutant was identi-
fied by sequencing and mapping to the genomic sequence of
S. marcescens Db11 (for a complete list, see supplementary
table S9, Supplementary Material online). Of the 12 mutants,
four loci had also been identified in a previous solid medium-
based screen (Kurz et al. 2003). These include those involved
in O antigen biosynthesis and siderophore production. The
availability of the complete sequence combined with recent
findings (Murdoch et al. 2011; English et al. 2012; Fritsch et al.
2013) revealed a hitherto unsuspected contribution of a T6SS
to the pathogenic capability of S. marcescens, either directly or
by providing a competitive fitness advantage against other
bacteria in vivo. The previously isolated mutants 22D9 and
7D1 (Kurz et al. 2003) were found to correspond to
SMDB11_2265 and SMDB11_2266, respectively, which are
both T6SS immunity proteins, 8C7 to SMDB11_1112, a
T6SS effector protein of unknown function, whereas the pre-
viously uncloned 23C11 corresponded to SMDB11_3455, a
T6SS-related, minor Hcp homolog (English et al. 2012; Fritsch
et al. 2013). As previously reported, this screen also led to the
isolation of a mutant in the swrA gene responsible for the
biosynthesis of the surfactant Serrawettin W2 (Pradel et al.
2007). Additional mutants of interest include one containing
an insert in a wza homolog, potentially involved in capsule
biosynthesis, and three deficient in respiration (JESM266,
JESM268, JESM271; supplementary table S9, Supplementary
Material online). None of these latter mutants showed a
defect in growth under standard conditions. This raises the
possibility that the nematode intestine represents a restrictive
respiratory environment.
The combined results of this and the previously published
screens (Kurz et al. 2003) identified 30 loci important for the in
vivo virulence of Db10 and/or Db11. Among the 30 genes, 22
are conserved in SM39. Of these, 11 are conserved in all of the
four other Serratia strains analyzed (supplementary table S9,
Supplementary Material online). The proportions of virulence
genes conserved between Db11 and SM39 (73%) and be-
tween this common set and the other Serratia strains (50%)
are markedly lower than the equivalent proportions of the
entire gene sets (84.5% and 71%, respectively). This presum-
ably reflects the different tropisms of the different species and
the host-specific nature of many virulence factors.
Origins of Antimicrobial Resistance in SM39 and Db11
Intrinsic Resistance
A large number of genes related to antimicrobial resistance
are encoded on the chromosomes of both Db11 and the clin-
ical S. marcescens isolate SM39. As listed in table 2, we iden-
tified many efflux pumps belonging to five families: The ABC
superfamily, the major facilitator superfamily (MFS), the multi-
drug and toxic-compound extrusion (MATE) family, the small
multidrug resistance (SMR) family, and the resistance nodula-
tion division (RND) family. Among these, only smdAB (Matsuo
et al. 2008), sdeAB (Kumar and Worobec 2005), sdeXY (Chen
et al. 2003), smfY (Shahcheraghi et al. 2007), and ssmE
(Minato et al. 2008) had been characterized in previous
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studies. Most of the efflux pumps are shared by the two
strains although a few are strain-specific. In addition, a class
C beta-lactamase AmpC, two aminoglycoside acetyltrans-
ferases each having distinct substrate specificities, and a fos-
fomycin-inactivating enzyme (FosA) are encoded on the
chromosomes of the two strains (table 3). Thus, the overall
repertoire of the chromosomally encoded resistance genes is
largely similar in both strains despite their different origins, and
is highly conserved accounting for the high and broad intrinsic
resistance of S. marcescens (table 3). One notable difference
between the two strains is a mutation in the gyrA gene of the
clinically isolated SM39, generating a S83R substitution and
conferring resistance to quinolone (Weigel et al. 1998).
Acquired Antimicrobial Resistance Genes
Unlike Db11, SM39 carries two plasmids. The overall GC con-
tents of the two plasmids differ significantly from the
Table 2
Drug Efflux Pumps Found in the Genomes of SM39 and Db11
SM39
(SM39_)
Db11
(SMDB11_)
Gene IMP
(SM39_/SMDB11_)
MFP
(SM39_/SMDB11_)
OMP
ABC type
0414-0415 0354-0355 smdAB smdA, smdB — —
1134-1135 0964-0965 macAB macB macA —
1329-1331 1118-1120 etsABC etsB etsA etsC
4783-4785 4552-4554 — 4784/4553 4783/4552 —
4785/4554 — —
RND type
0448-0449 0369-0370 sdeXY sdeY sdeX —
1281-1282 1059-1060 — 1281/1059 1282/1060 —
1400-1401 1196-1197 sdeAB sdeB sdeA —
Not found 1254A-1255A — SMDB11_1254A SMDB11_1255A SMDB11_1256
1913-1915 Not found — SM39_1914 SM39_1913 SM39_1915a
1920-1922 1741-1743 — 1921/1742 1922/1743 SMDB11_1741a
Not found 1698-1699 — SMDB11_1699 SMDB11_1698 —
1958 Not found — SM39_1958 — —
3100 2891 acrD acrD — —
3162-3164 2945-2947 sdeCDE sdeD, sdeE sdeC —
MFS type
467 390 fsr fsr — —
1351 1140 mdtG mdtG — —
1810 1629 — 1810/1629 — —
Not found 1759 tetA tetA — —
2164 1961 smfY smfY — —
2273 2069 mdtH mdtH — —
2819 2580 bcr bcr — —
3165 2948 mdtD mdtD — —
3343-3344 3133-3134 emrAB emrB emrA SMDB11_3132a
4622 4024 emrD emrD — —
4391 4201 mdfA mdfA — —
4497 4107 — 4497/4107 — —
MATE type
1653 1463 mdtK mdtK — —
2598 2377 — 2598/2377 — —
3912 3713 dinF dinF — —
SMR type
2035 1855 ssmE 2035/1855 — —
2237-2238 2032-2033 mdtJI 2237/2032 — —
2238/2033 — —
4693 4462 sugE 4693/4462 — —
pSMC1_35 Not found qacE1 qacE1 — —
pSMC1_46 Not found qacE2 qacE2 — —
aSimilar to the NodT family protein but contains no membrane-spanning domain.
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chromosome (~59%): 61.5% for pSMC1 and 51.9% for
pSMC2. The plasmid pSMC2 carries a set of genes for conju-
gation (the tra and trb genes), and although lacking traJ and
traT, it can be transferred by conjugation from SM39 to E. coli
K-12 strain x1037 Rifr (data not shown). Although pSMC2
contains no gene related to virulence or drug resistance,
pSMC1 carries an integron that contains the aadA gene
encoding an aminoglycoside-30-adenylyltransferase, the
Table 3
Drug Resistance Profiles and Genetic Determinants Responsible for Each Resistance in Strains SM39, KS3, and Db11
Antimicrobial Agents
(Subclasses)
MIC (mg/ml) Putative Resistance Determinant
SM39 KS3a Db11 On Choromosome On pSMC1
Gene SM39/KS3 (SM39_) Db11 (SMDB11_) Gene
b-Lactams
Piperacillin (PEN) 8 2 2 ampC 1721 1530 blaCMY, blaIMP
Faropenem (PEM) >256 4 4 ampC 1721 1530 blaCMY, blaIMP
Cephalothin (1st CEP) >256 >256 >256 ampC 1721 1530 blaCMY, blaIMP
Cefuroxime (2nd CEP) >256 >256 >256 ampC 1721 1530 blaCMY, blaIMP
Cefmetazol (2nd CEP) >256 32 16 ampC 1721 1530 blaCMY, blaIMP
Cefotaxime (3rd CEP) >256 0.5 1 — — — blaCMY, blaIMP
Ceftazidime (3rd CEP) 256 0.25 1 — — — blaCMY, blaIMP
Ceftriaxone (3rd CEP) >256 0.5 0.25 — — — blaCMY, blaIMP
Latamoxef (3rd CEP) >256 0.25 0.125 — — — blaCMY, blaIMP
Cefbuperazone (3rd CEP) >256 0.5 0.5 — — — blaCMY, blaIMP
Cefotetan (3rd CEP) >256 0.5 0.5 — — — blaCMY, blaIMP
Cefpirome (4th CEP) 32 0.25 0.25 — — — blaCMY, blaIMP
Cefepime (4th CEP) 32 0.25 0.25 — — — blaCMY, blaIMP
Aztreonam (MONO) 8 0.13 0.25 — — — blaCMY, blaIMP
Imipenem (CARB) 16 0.5 0.5 — — — blaIMP
Meropenem (CARB) 32 0.03 0.03 — — — blaIMP
Aminoglycosides
Streptomycin >128 4 >128b acc(6)-Id 1693 1504 aadA
Tobramycin 128 32 32 aac(60)-Ic 3758 3638 aadA
Amikacin 64 16 16 aac(60)-Ic 3758 3638 aadA
Arbekacin 64 16 16 aac(60)-Ic 3758 3638 aadA
Kanamycin 128 32 32 aac(60)-Ic 3758 3638 aadA
Spectinomycin >512 32 16 aac(60)-Ic 3758 3638 aadA
Gentamycin 16 4 4 — — — aadA
Quinolones
Levoﬂoxacin 4 4 0.25 gyrAc [+] in 2886 [] in 2665 —
Sparﬂoxacin 4 4 0.5 gyrAc [+] in 2886 [] in 2665 —
Ciproﬂoxacin 4 4 0.25 gyrAc [+] in 2886 [] in 2665 —
Tosuﬂoxacin 2 2 0.125 gyrAc [+] in 2886 [] in 2665 —
Macrolides
Erythromycin 128 128 128 macAB 1134_1135 0964_0965 —
Josamycin >512 >512 >512 macAB 1134_1135 0964_0965 —
Others
Tetracycline 16 16 64 tetA Not found 1759 —
Rifampicin 16 16 16 — — — —
Fosfomycin >512 >512 >512 fosA 2306 2100 —
Sulfamethoxazole >128 >128 >128 Unknown Unknown sulI1/2
Ethidium bromide >512 >512 >512 ssmE 2035 1855 qacE1/2
Benzalkonium chloride 128 128 128 — — — —
HgCl2 32 8 8 — — — mer operon
NOTE.—PEN, penicillin; PEM, penem; 1st CEP, 1st generation cephalospoin; 2nd CEP, 2nd generation cephalospoin; 3rd CEP, 3rd generation cephalospoin; 4th CEP, 4th
generation cephalospoin; MONO, monobactam; CARB, carbapenem.
aKS3 is a pSMC1-cured SM39 derivative.
bThe rpsL gene of Db11 contains a point mutation which confers streptomycin resistance on this strain.
cMutation in gyrA. The S83R mutation in the quinolone resistance-determining region.
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blaCMY-8 gene encoding a class C beta-lactamase which in-
activates a much broader range of beta-lactams than the chro-
mosomally encoded class C beta-lactamase (AmpC), and the
blaIMP-1 gene encoding a metal beta-lactamase (MBL). In
addition, pSMC1 contains two copies of the qacE gene, asso-
ciated with resistance to a range of disinfectants (Kucken et al.
2000), and two copies of the sulfonamide resistance gene
(sulI) as well as a transposon encoding the mer operon for
mercury resistance (fig. 6A).
Comparison of a pSMC1-cured SM39 derivative (KS3) with
the wild type showed that the high level of resistance dis-
played by SM39 to beta-lactams, aminoglycosides and mer-
cury is accounted for by the presence of pSMC1. Compared
with SM39, KS3 was great or equal to four more sensitive to
FIG. 6.—Genomic features and a possible evolutionary process of the pSMC1 multidrug-resistant plasmid of SM39. (A) Genomic comparison of pSMC1
and p07-406, an IncP plasmid of Pseudomonas aeruginosa. Although significant differences were observed in the region corresponding to a Tn501-like
transposon and the region corresponding to an integron-carrying transposon, the backbones of the two plasmid genomes are nearly identical and their GC
content is significantly higher than that of the Serratia marcescens chromosomes and rather similar to that of Pseudomonas species, suggesting that pSMC1
originated from Pseudomonas species. (B) Structural comparison of the integron of pSMC1 with that on pK29 of Klebsiella pneumoniae. The difference in
genetic structure between the two integrons could be generated by two inversion events and by insertion of IS elements and acquisition/duplication of
several genes.
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22 of the 36 antimicrobial agents tested; 14 of the 16 beta-
lactams, all of the seven aminoglycosides, and to mercury.
The 14 beta-lactams included carbapenems, the resistance
to which is attributable to MBL. The exception is resistance
to fluoroquinolones, which, as mentioned above, is attribut-
able to the chromosomal mutation in gyrA (table 3).
Plasmid pSMC1 exhibits a remarkable similarity to an IncP
plasmid of Pseudomonas aeruginosa, p07-406 (Li et al. 2008)
(fig. 6A). The backbones of the two plasmids encoding the tra
region and replication functions are nearly identical in gene
compliment and with a GC content (64.1–66.1%) character-
istic of pseudomonads. The main differences concern their
genetic cargo encoding multiple drug resistance. This is con-
sistent with the notion that Pseudomonas species are the
original hosts for IncP plasmids with high GC backbones
(Thorsted et al. 1998). However, as the integron-containing
region of pSMC1 is also high similarity to that on plasmid
pK29 of Klebsiella pneumoniae (Chen et al. 2007) although
complex rearrangements including inversion and gene dupli-
cation have occurred, it suggests that these closely related
plasmids have become widely disseminated in the
Enterobacteriaceae (fig. 6B).
Concluding Remarks
We selected two S. marcescens strains from contrasting
sources in an attempt to maximize our ability to capture the
genomic diversity of this ubiquitous enteric species. Through
our comparative analysis, we have defined a core genome of
S. marcescens as well as that of the genus, although it should
be noted that the latter gene set was generated from free-
living Serratia species only. The former gene set defines the
intrinsic metabolic capacities, virulence, and multidrug resis-
tance of this opportunistic pathogen. Analysis of strain-specific
genes or genomic regions has further revealed a high level of
genomic diversity and plasticity of S. marcescens, which re-
flects the diversity of niches that this species can occupy. In
fact, among the SM39-specific genes, many genes that are
implicated in the high virulence potential of this clinical isolate
have been identified, this includes many virulence-related
genes found within the core genome of S. marcescens.
Furthermore, analysis of the pSMC1 plasmid of SM39 has
revealed that it encodes MBL and many other drug resistance
determinants and is responsible for the extremely high level of
multidrug resistance of the strain. We were able to propose a
possible origin and evolution of pSMC1 on the basis of its
genomic features. These data, combined with available tools
for functional genomic analysis such as that described by
Petty et al. (2006: 1701–1708), will accelerate research
on S. marcescens in numerous domains and provide new in-
sights into the genetic mechanisms responsible for the emer-
gence of pathogens highly resistant to multiple antimicrobial
agents.
Supplementary Material
Supplementary figures S1–S5 and tables S1–S9 are available
at Genome Biology and Evolution online (http://www.gbe.
oxfordjournals.org/).
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